USFDA approval Binimetinib marks a significant advancement in cancer treatment options for patients.
Author: Krista T. Calloway
HLB Pharmaceutical plant: Proven Expansion with New Facility
HLB Pharmaceutical plant secures annual capacity of 700 million tablets, showcasing growth in the pharma sector.
AstraZeneca acquisition Rhythm Pharmaceuticals: A Smart Move?
AstraZeneca acquisition Rhythm Pharmaceuticals could reshape the pharma landscape.
CagriSema US approval: Is it the Best Path Forward?
CagriSema US approval is anticipated by Novo. Discover the latest updates on its potential impact and significance.
FDA Approval for Ilumya: Proven Relief for Joint Pain
FDA approval for Ilumya brings proven relief options for adults with joint pain from psoriatic arthritis.
Karnataka HC hospital directive: A Wrong Move for Transparency
Karnataka HC hospital directive raises concerns over transparency in medicine pricing.
Hong Kong Stock Exchange Tightens Order Price Limit: Quick Changes
Hong Kong Stock Exchange is tightening the order price limit to five times. Find out what this means for investors starting Nov. 2.
Vasculitis Drug Approval: Questionable Data Raises Concerns
Vasculitis drug approval data raises reliability concerns as Japan’s health ministry questions findings.
Cancer drug price cuts: India slashes prices by 70%!
Cancer drug price cuts are set to save patients up to 70% starting November 9.
Dr Reddy’s Laboratories stock: Best Proven Insights
Dr Reddy’s Laboratories stock is in focus as USFDA completes inspection at FTO-9 plant, signaling potential positive developments.

